GP Georges

Chief Executive Officer

Therapeutic Areas

Drug	Indication	Phase
Dendocrin™	Secondary Hyperparathyroidism (SHPT) in Stage 3 & 4 Chronic Kidney Disease (CKD) with Vitamin D Deficiency	Phase 3